These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advances in HIV/AIDS care require hard choices. Lawrence J Manag Care; 1998 Oct; 7(10):39-43. PubMed ID: 10185863 [No Abstract] [Full Text] [Related]
4. Attempting human immunodeficiency virus disease management at the state level. Kozma CM Manag Care Interface; 1999 Oct; 12(10):58-9. PubMed ID: 10623009 [No Abstract] [Full Text] [Related]
6. [Economic burden and clinical course of HIV infection and AIDS today: how the variation of natural history, available treatments, and strictly related costs play a role in needs of health care]. Manfredi R; Calza L; Gramegna A; Bocchi F; Fiacchi P; Corsini D; Chiodo F Recenti Prog Med; 2001 Nov; 92(11):648-54. PubMed ID: 11765655 [TBL] [Abstract][Full Text] [Related]
7. Economic impact of delaying or preventing AIDS in persons with HIV. Pinkerton SD; Holtgrave DR Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025 [TBL] [Abstract][Full Text] [Related]
8. [Clinical and economic impact of new antiretroviral treatments]. Moreno Guillén S; Pérez Elías MJ Rev Clin Esp; 1999 Feb; 199(2):53-4. PubMed ID: 10216393 [No Abstract] [Full Text] [Related]
9. 30 years of pediatric HIV/AIDS treatment: a time of breakthroughs, innovation. Pediatr Ann; 2011 Jul; 40(7):340-1. PubMed ID: 21736254 [No Abstract] [Full Text] [Related]
10. Funding shortages challenge AIDS drug assistance program. Engle L Body Posit; 1998 Aug; 11(8):12. PubMed ID: 11365693 [TBL] [Abstract][Full Text] [Related]
11. AIDS: mixed news for patients: medications made more accessible in Africa and the Caribbean than in U.S. Sofer D Am J Nurs; 2004 Aug; 104(8):20. PubMed ID: 15300025 [No Abstract] [Full Text] [Related]
12. Uganda cuts AIDS drug deal. IAPAC Mon; 2001 Feb; 7(2):40. PubMed ID: 11302022 [No Abstract] [Full Text] [Related]
13. Economic impact of HIV. Veenstra N; Whiteside A Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):197-210. PubMed ID: 15778110 [TBL] [Abstract][Full Text] [Related]
14. HIV disease management: new technologies improve outcomes and contain costs. Valenti WM AIDS Read; 2002 Feb; 12(2):64-6. PubMed ID: 11905142 [TBL] [Abstract][Full Text] [Related]
15. [The cost of an HIV patient. Lack of funds for optimal treatment?]. Stoll M; Schulte E; Claes C; Graf von der Schulenburg JM; Schmidt RE MMW Fortschr Med; 2001 Apr; 143 Suppl 1():72-7. PubMed ID: 11373789 [TBL] [Abstract][Full Text] [Related]
16. Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine. Biddle AK; Simpson KN Value Health; 2000; 3(3):186-201. PubMed ID: 16464183 [TBL] [Abstract][Full Text] [Related]
18. Perceived barriers to adherence as described by individuals with HIV disease. Wurth S Ky Nurse; 2005; 53(1):11. PubMed ID: 15748005 [No Abstract] [Full Text] [Related]
19. Lifetime costs of AIDS drops below $100,000. AIDS Alert; 1997 Nov; 12(11):128-9. PubMed ID: 11364771 [TBL] [Abstract][Full Text] [Related]
20. Simplifying HIV therapeutics, and the global treatment of AIDS. Laurence J AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889 [No Abstract] [Full Text] [Related] [Next] [New Search]